The Solution:

Developed by SMART Biotech, Stimmunology technology has been shown to close the Window Period by enabling the detection of HIV/HCV-specific lymphocytes that have been primed in vivo, via their antibody production in vitro.
 
Based on the Stimmunology technology, SMARTube™ HIV&HCV is a blood pre-treatment device, which enhances the production of  antibodies to enable the closing of the Window Period, thus allowing the most efficient use of antibody tests (ELISA) in this period.

By using SMARTube™ missed (hidden) infections,

due to the Window Period, will be detected

The concept of the SMARTube™ HIV&HCV  is to enable antibody production, in a small blood sample, within days from infection, without having to wait for the body to produce antibodies weeks or months later. This is done by pushing HIV and/or HCV primed cells for antibody production at levels that can be detected by current testing.

SMARTube™ closes the Window Period- the vast majority of infected people can be detected within a week from the infection.
 

SMARTube™ HIV&HCV Benefits:

SMARTube™  enables detection within days of exposure - the only system that closes the Window Period

SMARTube™  increases sensitivity, with higher levels of antibodies for better detection

SMARTube™  increases specificity, with a lower number of false positives
 
SMARTube™  saves cost of repeat testing and enables better planning of budget
 
SMARTube™  enables detection of recent infections which are the key to control the HIV/HCV epidemics 

SMARTube™  enables measurement of incidence levels for more effective and focused prevention program